கட்டி சிகிச்சை புலம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கட்டி சிகிச்சை புலம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கட்டி சிகிச்சை புலம் Today - Breaking & Trending Today

Novocure Reports First Quarter 2021 Financial Results and Provides Company Update

Novocure Reports First Quarter 2021 Financial Results and Provides Company Update
Quarterly net revenues of $134.7 million with 80% gross margin
Interim analysis for phase 3 pivotal LUNAR trial in non-small cell lung cancer concluded with favorable recommendation to continue the trial with reduced sample size
Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2021, highlighting continued commercial strength despite changes in patterns of care in some regions driven by COVID-19, as well as continued progress across the company s clinical and product development programs. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields). TTFields are electric fields that disrupt cancer cell division. ....

New York , United States , New Hampshire , Optune Lua , Adam Daney , William Doyle , Asaf Danziger , Exchange Commission , Merck Co Inc , Zai Lab , Drug Administration , Tumor Treating Fields , Tumor Treating Field , Chief Executive , Greater China , Investor Relations , Tumor Treating , Annual Report , Private Securities Litigation Reform Act , Balance Sheets , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஹாம்ப்ஷயர் , வில்லியம் டாய்ல் , பரிமாற்றம் தரகு , மெர்க் இணை இன்க் ,

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

Pre-specified interim analysis concluded with favorable recommendation to continue the LUNAR trial DMC stated accrual to 534 patients is likely unnecessary and possibly unethical for patients randomized to control arm and recommended a shortened trialST. HELIER, Jersey (BUSINESS WIRE) $NVCR #lcsm Novocure (NASDAQ: NVCR) today announced an update regarding its phase 3 ....

New York , United States , New Hampshire , Asaf Danziger , William Doyle , Exchange Commission , Drug Administration , Tumor Treating Fields , Investigational Device Exemption , Tumor Treating Field , Treating Fields , Annual Report , Private Securities Litigation Reform Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஹாம்ப்ஷயர் , வில்லியம் டாய்ல் , பரிமாற்றம் தரகு , கட்டி சிகிச்சை புலங்கள் , கட்டி சிகிச்சை புலம் , சிகிச்சை புலங்கள் , ஆண்டு அறிக்கை , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

NovoCure (NVCR) Q4 2020 Earnings Call Transcript

NovoCure (NVCR) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
NovoCure (NASDAQ: NVCR)
Ladies and gentlemen, thank you for standing by, and welcome to the NovoCure fourth-quarter and full-year 2020 earnings conference call. [Operator instructions] Please be advised that today s conference is being recorded. [Operator instructions] I would now like to hand the conference over to your speaker today, Gabrielle Fernandes, director of investor relations. Thank you.
Please go ahead, ma am.
Gabrielle Fernandes
Director of Investor Relations
Good morning, everyone, and thank you for joining us to review NovoCure s fourth-quarter and full-year 2020 performance. I am joined on the phone by our executive chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for ....

Hong Kong , Optune Lua , Jason Wittes , Ely Benaim , Jason Bednar , Ashley Cordova , Ttfields Optune , Jason Wittes Northland , Pritesh Shah , Vijay Kumar , Gabrielle Fernandes , Larry Biegelsen , Greg Gilbert , Greg Gilbert Truist , Dan Clark Mizuho , Piper Sandler , Asaf Danziger , Dan Clark , Vijay Kumar Evercore , Jason Bednar Piper Sandler , Difei Yang , Swiss Federal Office Of Public Health , European Network For Gynecological Oncological , French Ministry Of Health , Wells Fargo , Motley Fool Novocure ,